Volume 6, Issue 4, Pages (October 2009)

Slides:



Advertisements
Similar presentations
Volume 6, Issue 4, Pages (October 2009)
Advertisements

Volume 45, Issue 6, Pages (December 2016)
Volume 42, Issue 2, Pages (February 2015)
Volume 5, Issue 1, Pages (January 2009)
Volume 22, Issue 4, Pages e4 (October 2017)
Volume 28, Issue 2, Pages (February 2008)
Volume 43, Issue 4, Pages (October 2015)
Cutaneous RANK–RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans.
Volume 6, Issue 5, Pages (November 2009)
Volume 35, Issue 4, Pages (October 2011)
Volume 34, Issue 3, Pages (March 2011)
Volume 30, Issue 4, Pages (April 2009)
Accelerated Migration of Respiratory Dendritic Cells to the Regional Lymph Nodes Is Limited to the Early Phase of Pulmonary Infection  Kevin L Legge,
Cheryl Y. Chan, Ashley L. St. John, Soman N. Abraham  Immunity 
Volume 40, Issue 2, Pages (February 2014)
Volume 41, Issue 3, Pages (September 2014)
Volume 24, Issue 2, Pages (February 2006)
B-cell differentiation associates with down-regulation of vimentin expression. B-cell differentiation associates with down-regulation of vimentin expression.
Volume 30, Issue 3, Pages (March 2009)
The Role of Dendritic Cells in S
Volume 15, Issue 6, Pages (June 2014)
Volume 37, Issue 4, Pages (October 2012)
Volume 40, Issue 3, Pages (March 2014)
Volume 6, Issue 5, Pages (November 2009)
Dynamic Interplay among Monocyte-Derived, Dermal, and Resident Lymph Node Dendritic Cells during the Generation of Vaccine Immunity to Fungi  Karen Ersland,
Volume 38, Issue 1, Pages (January 2013)
Volume 29, Issue 1, Pages (July 2008)
Volume 29, Issue 2, Pages (August 2008)
Volume 17, Issue 5, Pages (May 2015)
Volume 29, Issue 2, Pages (August 2008)
Volume 21, Issue 4, Pages (October 2004)
Volume 7, Issue 2, Pages (February 2010)
Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation  Jeffery J. Auletta,
Volume 37, Issue 1, Pages (July 2012)
Volume 25, Issue 3, Pages (September 2006)
Volume 33, Issue 4, Pages (October 2010)
Mycobacterium tuberculosis Inhibits Neutrophil Apoptosis, Leading to Delayed Activation of Naive CD4 T cells  Robert Blomgran, Ludovic Desvignes, Volker.
Protective Capacity of Memory CD8+ T Cells Is Dictated by Antigen Exposure History and Nature of the Infection  Jeffrey C. Nolz, John T. Harty  Immunity 
Volume 34, Issue 5, Pages (May 2011)
Interleukin-1β But Not Tumor Necrosis Factor is Involved in West Nile Virus-Induced Langerhans Cell Migration from the Skin in C57BL/6 Mice  Scott N.
Volume 45, Issue 6, Pages (December 2016)
Volume 37, Issue 5, Pages (November 2012)
Tamar Hermesh, Bruno Moltedo, Thomas M. Moran, Carolina B. López 
Volume 33, Issue 6, Pages (December 2010)
Volume 6, Issue 5, Pages (November 2009)
Volume 22, Issue 3, Pages (March 2005)
Volume 29, Issue 6, Pages (December 2008)
Volume 28, Issue 1, Pages (January 2008)
Volume 6, Issue 6, Pages (December 2009)
Volume 48, Issue 4, Pages e4 (April 2018)
Volume 33, Issue 4, Pages (October 2010)
Volume 22, Issue 2, Pages (February 2005)
Volume 15, Issue 4, Pages (April 2014)
Oral Tolerance Can Be Established via Gap Junction Transfer of Fed Antigens from CX3CR1+ Macrophages to CD103+ Dendritic Cells  Elisa Mazzini, Lucia Massimiliano,
Katelyn T. Byrne, Robert H. Vonderheide  Cell Reports 
Jeffery M. Cowden, Mai Zhang, Paul J. Dunford, Robin L. Thurmond 
Volume 5, Issue 1, Pages (January 2009)
Volume 22, Issue 5, Pages e5 (November 2017)
CD301b+ Dermal Dendritic Cells Drive T Helper 2 Cell-Mediated Immunity
Volume 40, Issue 3, Pages (March 2014)
Volume 21, Issue 2, Pages (February 2017)
Volume 34, Issue 4, Pages (April 2011)
Volume 41, Issue 1, Pages (July 2014)
Volume 22, Issue 5, Pages e5 (November 2017)
Linda J. Johnston, Nicholas J.C. King 
Volume 42, Issue 4, Pages (April 2015)
Katelyn T. Byrne, Robert H. Vonderheide  Cell Reports 
Volume 9, Issue 6, Pages (June 2011)
Volume 36, Issue 5, Pages (May 2012)
Volume 24, Issue 2, Pages (February 2006)
Presentation transcript:

Volume 6, Issue 4, Pages 331-342 (October 2009) Mast Cells Augment Adaptive Immunity by Orchestrating Dendritic Cell Trafficking through Infected Tissues  Christopher P. Shelburne, Hideki Nakano, Ashley L. St. John, Cheryl Chan, James B. McLachlan, Michael D. Gunn, Herman F. Staats, Soman N. Abraham  Cell Host & Microbe  Volume 6, Issue 4, Pages 331-342 (October 2009) DOI: 10.1016/j.chom.2009.09.004 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 MCs Are Required for the Maximal Induction of a Protective Primary Humoral Response to E. coli (A) GMT of TNP-specific serum IgG in WT and MC-deficient Wsh/Wsh (Wsh) mice 14 days after injection with 1 × 106 TNP-labeled E. coli. n = 9–11. ∗p < 0.05 compared to Wsh mice using unpaired Student's t test. (B) The number of E. coli colony-forming units (CFU) per bladder of WT mice that received 150 μl serum from naive or TNP E. coli-immunized WT or Wsh mice. n = 9–11. ∗p < 0.05 comparing responses in recipient mice that received serum from naive or E. coli-challenged mice; ∗∗p < 0.05 comparing the responses between recipient mice that received serum from E. coli-challenged WT and Wsh mice. (C) GMT of TNP-specific serum IgG in WT, MC-deficient W/Wv, and footpad WT-MC-repleted W/Wv mice injected with 1 × 106 TNP-labeled E. coli. n = 12 for WT, n = 14 for W/Wv, and n = 5 for WT-MC reconstituted W/Wv samples. ∗p = 0.001 compared to W/Wv mice. (D) GMT of TNP-specific serum IgG in footpad WT-MC-repleted or TNF−/− MC-repleted W/Wv mice injected with 1 × 106 TNP-labeled E. coli. n = 5 for each group. ∗p = 0.001. Data in (B)–(D) were analyzed for statistical significance with one-way ANOVA and Tukey's posttest. Error bars represent the mean ± SD. Cell Host & Microbe 2009 6, 331-342DOI: (10.1016/j.chom.2009.09.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Challenge of Footpads with E. coli Induces an MC-TNF-Dependent Increase in DC Numbers (A) Analysis of WT footpad, 3 hr after injection of E. coli or saline, for MHC Class II (DCs), CD31 (blood vessel endothelium), and avidin (MCs) by confocal microscopy. Scale bars = 100 μM. E = epidermis, D = Dermis, LC = Langerhans cells (arrowheads). The arrow denotes a DC bundle. (B) Total number of CD11c+ DCs in single cell suspensions of footpads at the indicated time-points. N = 4-5 for each time-point. ∗p < 0.05 compared to saline controls. Data was analyzed for statistical significance with one-way ANOVA and Tukey's posttest. (C) Total number of CD11c+ DCs in single cell suspensions of W/Wv, WT-MC or TNF−/− MC repleted W/Wv footpads, 3 hr after saline or E. coli challenge. N = 4 for each sample. ∗p < 0.05 compared to saline controls and ∗∗p < 0.05 comparing E. coli challenged WT-MC repleted W/Wv footpad samples to W/Wv and TNF−/− MC-repleted W/Wv samples. Data was analyzed for statistical significance with one-way ANOVA and Tukey's posttest. (D) The gating strategy to identify footpad (FP)-DC subsets. The table inset identifies each subset. (E) Total number of each FP-DC subset, regions 1-4, 3 hr after saline or E. coli challenge. N = 6. ∗p < 0.05 comparing E. coli challenged samples to saline controls within each FP-DC subset. Data was analyzed for statistical significance using unpaired Student's t test. Error bars represent the mean ± SD. Cell Host & Microbe 2009 6, 331-342DOI: (10.1016/j.chom.2009.09.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 MC-TNF Is Required for the Optimal Induction of E-Selectin Expression after Challenge with E. coli (A) Analysis of WT footpad tissue for E-selectin, CD31 (blood vessel endothelium), and avidin (MCs) by confocal microscopy. E, epidermis; D, dermis. Scale bar, 100 μM. (Arrows) CD62E+ endothelial segments. Similar results were obtained in three separate experiments. (B) Enumeration of E-selectin+ blood vessel segments in 700 μM × 700 μM confocal images derived from 10 μM sections of WT, W/Wv, or WT-MC or TNF−/− MC-repleted W/Wv footpads 3 hr after saline or E. coli challenge. Data are represented as the E. coli-induced fold increase in the percent of E-selectin+ blood vessel segments compared to saline-treated controls. n = 25–30 fields from three separate experiments. ∗p < 0.05 and ∗∗p < 0.05, comparing WT or WT-MC-repleted W/Wv samples to W/Wv or TNF−/− MC-repleted W/Wv samples, respectively. (C) Total number of CD11c+ DCs in single-cell suspensions of footpad 3 hr after challenge with saline or E. coli. n = 5. ∗p < 0.05 compared to saline controls; ∗∗p < 0.05 comparing E. coli challenged samples. (D) Total number of each FP-DC subset, regions 1–4, from mice treated with anti-E-selectin or Rat IgG1 3 hr after challenge with saline or E. coli. n = 5. ∗p < 0.05 comparing E. coli-challenged samples to saline controls within each FP-DC subset; ∗∗p < 0.05 comparing E. coli-challenged samples from anti-E-selectin to rat IgG1-treated mice within each FP-DC subset. Data in (B)–(D) were analyzed for statistical significance with one-way ANOVA and Tukey's posttest. Error bars represent the mean ± SD. Cell Host & Microbe 2009 6, 331-342DOI: (10.1016/j.chom.2009.09.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 4 MC-TNF Is Required to Mobilize DCs to DLNs after Footpad Challenge with E. coli (A) Total number of CD11c+/MHC Class II+ DCs in single-cell suspensions of DLN at 12, 24, or 48 hr after saline or E. coli challenge. n ≥ 10 DLNs for each time point. ∗p < 0.05 compared to saline controls; ∗∗p < 0.05 comparing the 24 hr to the 12 and 48 hr E. coli-challenged samples. (B) Total number of DCs in single cell suspensions of DLNs of WT, W/Wv, and WT MC-footpad repleted W/Wv mice 24 hr after challenge with saline or E. coli. N = 6 for WT and W/Wv samples. N = 4 for MC-repleted W/Wv samples. ∗p < 0.05 compared to saline controls. ∗∗p < 0.05 comparing E. coli-challenged MC-sufficient samples to the E. coli-challenged W/Wv samples. (C) Total number of DCs in single-cell suspensions of DLNs of WT and TNF−/− mice 24 hr after challenge with saline or E. coli. n = 4 for each sample. ∗p < 0.001 compared to saline controls; ∗∗p < 0.001 comparing E. coli-challenged samples. (D) Total number of DCs in single-cell suspensions of DLNs of WT-MC-repleted W/Wv and TNF−/− MC-repleted W/Wv mice 24 hr after challenge with saline or E. coli. n = 4 for each sample. ∗p < 0.001 compared to saline controls; ∗∗p < 0.001 comparing E. coli-challenged samples. Data in (A)–(D) were analyzed for statistical significance with one-way ANOVA and Tukey's posttest. Error bars represent the mean ± SD. Cell Host & Microbe 2009 6, 331-342DOI: (10.1016/j.chom.2009.09.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 5 E. coli Infection Induces the Continual and Serial Migration of DCs from the Bloodstream through the Footpad prior to Their Egress to the DLN (A) CFSE or vehicle was injected into footpads. After 4 hr, single-cell footpad suspensions were stained with anti-CD11c and analyzed by flow cytometry. (B) CFSE or vehicle was injected into footpads. After 4 hr, footpads were injected with E. coli or saline. After 24 hr, single-cell suspensions of DLNs were analyzed by flow cytometry for CFSE+ DCs (identified as CD11c+/MHC Class II+). (Top) The percentage of CFSE+ DCs in gated DC DLN populations. n = 4–6. p < 0.05 comparing saline to E. coli-challenged samples. (Bottom) The side scatter profile of the entire DLN population of each sample. (C) Footpads were challenged with E. coli or saline. At the indicated times, CFSE or vehicle was injected into footpads. At 24 hr after saline or E. coli challenge, DLN single-cell suspensions were stained for DCs (identified as CD11c+/MHC Class II+) and analyzed by flow cytometry. Histograms represent the percent of CFSE+ DCs in gated DLN DC populations. (Top) CFSE or vehicle injected 6 hr after E. coli challenge. n = 6. p < 0.05 comparing saline to E. coli-challenged samples. (Middle) CFSE or vehicle injected 12 hr after E. coli challenge. n = 6. p < 0.05 comparing saline to E. coli-challenged samples. (Bottom) CFSE or vehicle was injected 4 hr before and 6 and 12 hr (“Multiple Label”) after E. coli or saline challenge. n = 6. p < 0.05 comparing saline to E. coli-challenged samples. All data were evaluated for statistical significance using unpaired Student's t test. Cell Host & Microbe 2009 6, 331-342DOI: (10.1016/j.chom.2009.09.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 6 E. coli Infection Induces E-Selectin-Dependent Increases in DCs in DLNs and Humoral Responses (A) Total number of MHC Class II+/CD11c+ DCs in the DLNs of anti-E-selectin or rat IgG1-treated mice 24 hr after challenge with saline or E. coli. n = 3–5. Data were analyzed for statistical significance with one-way ANOVA and Tukey's posttest. ∗p < 0.05 compared to saline controls; ∗∗p = 0.01 comparing E. coli-challenged samples. (B) Confocal analysis of 10 μM sections derived from WT DLNs 3 hr after E. coli challenge. Sections were stained for anti-E-selectin, anti-PNAD (high endothelial venules), and anti-CD11c (DCs). Scale bar, 100 μM. The boxed inset is represented in the image to the right. Scale bar, 20 μM. Similar results were obtained in three separate experiments. (C) GMT of TNP-specific serum IgG in TNP E. coli-challenged mice treated with anti-E-selectin or rat IgG1. n = 5 for each group. Significance between saline and E. coli-challenged samples was evaluated using ANOVA with Tukey's posttest. ∗p = 0.001. Error bars represent the mean ± SD. Cell Host & Microbe 2009 6, 331-342DOI: (10.1016/j.chom.2009.09.004) Copyright © 2009 Elsevier Inc. Terms and Conditions